Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study.

@article{Clair2011NeuroprotectionDC,
  title={Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study.},
  author={Daniel G. Clair and L N Hopkins and Manish Mehta and Karthikeshwar Kasirajan and M. G. Schermerhorn and Claudio Sch{\"o}nholz and Christopher J Kwolek and Mark K. Eskandari and Richard James Powell and Gary M Ansel},
  journal={Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions},
  year={2011},
  volume={77 3},
  pages={420-9}
}
BACKGROUND Each of the embolic protection devices used in carotid artery stenting (CAS) has advantages and disadvantages. The prospective, multicenter, single-arm EMPiRE Clinical Study investigated a proximally placed device (GORE Flow Reversal System) that provides distal neuroprotection during CAS by reversing blood flow in the internal carotid artery, thereby directing emboli away from the brain. METHODS The study evaluated 30-day outcomes in 245 pivotal high-surgical-risk patients (mean… CONTINUE READING